Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.88 |
| ▸ | MEN1 | O00255 | 4/20 | 0.88 |
| ▸ | MAPT | P10636 | 4/20 | 0.88 |
| ▸ | HPGD | P15428 | 4/20 | 0.88 |
| ▸ | RECQL | P46063 | 4/20 | 0.88 |
| ▸ | BLM | P54132 | 4/20 | 0.88 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.88 |
| ▸ | APEX1 | P27695 | 2/20 | 0.88 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.88 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.88 |
| ▸ | RELA | Q04206 | 1/20 | 0.76 |
| ▸ | MAOA | P21397 | 5/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.72 |
| ▸ | CA12 | O43570 | 2/20 | 0.72 |
| ▸ | CA1 | P00915 | 2/20 | 0.72 |
| ▸ | CA7 | P43166 | 2/20 | 0.72 |
| ▸ | CA9 | Q16790 | 2/20 | 0.72 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.72 |
| ▸ | TP53 | P04637 | 2/20 | 0.72 |
| ▸ | THRB | P10828 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29508368 | 0.94 | KDM4E (1.00) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL941032 | 0.94 | KDM4E (1.00) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL38658338 | 0.90 | CA12 (0.84) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL13805434 | 0.90 | KDM4E (0.80) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL940860 | 0.90 | CA12 (0.84) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL2369012 | 0.87 | KDM4E (0.77) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL30608638 | 0.86 | RELA (1.00) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL941424 | 0.86 | RELA (1.00) | KDM4EMEN1MAPTHPGDRECQL | |
| SCHEMBL16401447 | 0.86 | KDM4E (0.65) | KDM4EMEN1MAPTHPGDRECQL | |
| Ellagic Acid SCHEMBL28824363 | 0.85 | KDM4E (0.92) | KDM4EMEN1MAPTHPGDRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023128710-A1 | TABLET CONTAINING MIXED EXTRACT OF CINNAMOMI RAMULUS AND MOUTAN RADICIS CORTEX AS ACTIVE INGREDIENT AND COMPOSITION DESIGNED TO ADMINISTER SPECIFIC DOSAGE THEREOF FOR TREATMENT | 주식회사 큐라클 | 2023-07-06 | — | — | WO | claimed |
| CN-113264975-B | An extract with antiinflammatory activity extracted from fructus Rosae Normalis rhizome and its application | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 2023-10-20 | — | — | CN | disclosed |
| WO-2023128710-A1 | TABLET CONTAINING MIXED EXTRACT OF CINNAMOMI RAMULUS AND MOUTAN RADICIS CORTEX AS ACTIVE INGREDIENT AND COMPOSITION DESIGNED TO ADMINISTER SPECIFIC DOSAGE THEREOF FOR TREATMENT | 주식회사 큐라클 | 2023-07-06 | — | — | WO | disclosed |
| CN-109765320-B | Content determination method for tendon and bone injury spraying agent | 贵州远程制药有限责任公司 | 2022-03-22 | — | — | CN | disclosed |
| WO-2021106856-A1 | COMPOSITION FOR IMPROVING URINARY TRACT FUNCTION AND COMPOSITION FOR IMPROVING BLOOD FLOW IN BLADDER | 小林製薬株式会社 | 2021-06-03 | — | — | WO | disclosed |
| WO-2021106857-A1 | COMPOSITION FOR PREVENTING OR RELIEVING URESIESTHESIA STRESS, AND COMPOSITION FOR IMPROVING SLEEP | 小林製薬株式会社 | 2021-06-03 | — | — | WO | disclosed |
| CN-109984975-A | With the Preparation method and use of antioxidant activity total phenol in a kind of apocarya grouts | 江苏省中国科学院植物研究所 | 2019-07-09 | — | — | CN | disclosed |
| CN-109765320-A | A kind of content assaying method for spray agent for treating tendon and bone injury | 贵州远程制药有限责任公司 | 2019-05-17 | — | — | CN | disclosed |
| CN-105837645-B | The method that 3- methoxyl group ellagic acid -4-O- β-D-Glucose glycosides is extracted from Camellia Leaves | 中南林业科技大学 | 2018-08-28 | — | — | CN | disclosed |
| CN-106259549-B | Air purification composition | 王婧宁 | 2017-05-17 | — | — | CN | disclosed |
| CN-1266421-B | Anticancer compounds | PEPLIN PTY LTD | 2014-06-18 | — | — | CN | disclosed |
| WO-2011098818-A1 | DIETARY SUPPLEMENT COMPOSITION | GOMEZ, RIGEL (PH) | 2011-08-18 | — | — | WO | disclosed |
| WO-2011094708-A2 | SMALL MOLECULES FOR THE MODULATION OF MCL-1 AND METHODS OF MODULATIING CELL DEATH, CELL DIVISION, CELL DIFFERENTIATION AND METHODS OF TREATING DISORDERS | DANA-FARBER CANCER INSTITUTE, INC (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2004064725-A2 | ORAL COMPOSITIONS AND METHODS FOR TREATMENT OF ADVERSE EFFECTS OR RADIATION | THE QUIGLEY CORPORATION (US) | 2004-08-05 | — | — | WO | disclosed |
| CN-1119144-C | Composition for external application | LION CORP (JP) | 2003-08-27 | — | — | CN | disclosed |
| EP-1289489-A2 | TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE | PENTAPHARM Ltd. (CH) | 2003-03-12 | — | — | EP | disclosed |
| WO-2001091715-A2 | TOPICAL AGENT FOR DERMATOLOGICAL USE CONTAINING 4-HYDROXYPHENYL-ALPHA-D-GLUCOPYRANOSIDE | PENTAPHARM LTD. (CH) | 2001-12-06 | — | — | WO | disclosed |
| CN-1266421-A | Anticancer compounds | PEPLIN PTY LTD (AU) | 2000-09-13 | — | — | CN | disclosed |
| CN-1187990-A | Composition for external application | LION CORP (JP) | 1998-07-22 | — | — | CN | disclosed |